Thubrikar Aortic Valve Announces Authorization to Expand the TAVI-1 CE Mark Trial with the Precision 2™ Delivery Catheter
A conversation on TAV durability
Dr. Jeffrey Popma, Dr. Danny Dvir, and Dr. Mano Thubrikar discuss at the Baim Institute of Clinical Research in Boston